99 related articles for article (PubMed ID: 7985493)
1. Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics.
Iwatsubo T; Hasegawa M; Ihara Y
Acta Neuropathol; 1994; 88(2):129-36. PubMed ID: 7985493
[TBL] [Abstract][Full Text] [Related]
2. Identification of septins in neurofibrillary tangles in Alzheimer's disease.
Kinoshita A; Kinoshita M; Akiyama H; Tomimoto H; Akiguchi I; Kumar S; Noda M; Kimura J
Am J Pathol; 1998 Nov; 153(5):1551-60. PubMed ID: 9811347
[TBL] [Abstract][Full Text] [Related]
3. Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy.
Driver-Dunckley ED; Zhang N; Serrano GE; Dunckley NA; Sue LI; Shill HA; Mehta SH; Belden C; Tremblay C; Atri A; Adler CH; Beach TG
J Neuropathol Exp Neurol; 2023 Apr; 82(5):438-451. PubMed ID: 37040756
[TBL] [Abstract][Full Text] [Related]
4. Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer's Disease and Related Dementias.
Hromadkova L; Siddiqi MK; Liu H; Safar JG
Cells; 2022 Sep; 11(19):. PubMed ID: 36230957
[TBL] [Abstract][Full Text] [Related]
5. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy.
Roemer SF; Grinberg LT; Crary JF; Seeley WW; McKee AC; Kovacs GG; Beach TG; Duyckaerts C; Ferrer IA; Gelpi E; Lee EB; Revesz T; White CL; Yoshida M; Pereira FL; Whitney K; Ghayal NB; Dickson DW
Acta Neuropathol; 2022 Oct; 144(4):603-614. PubMed ID: 35947184
[TBL] [Abstract][Full Text] [Related]
6. Neurodegenerative proteinopathies associated with neuroinfections.
Danics K; Forrest SL; Kapas I; Erber I; Schmid S; Törő K; Majtenyi K; Kovacs GG
J Neural Transm (Vienna); 2021 Oct; 128(10):1551-1566. PubMed ID: 34223998
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies.
Kametani F; Yoshida M; Matsubara T; Murayama S; Saito Y; Kawakami I; Onaya M; Tanaka H; Kakita A; Robinson AC; Mann DMA; Hasegawa M
Front Neurosci; 2020; 14():581936. PubMed ID: 33250706
[TBL] [Abstract][Full Text] [Related]
8. Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies.
Abey A; Davies D; Goldsbury C; Buckland M; Valenzuela M; Duncan T
Brain Pathol; 2021 Jan; 31(1):144-162. PubMed ID: 32810333
[TBL] [Abstract][Full Text] [Related]
9. Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease.
Kametani F; Hasegawa M
Front Neurosci; 2018; 12():25. PubMed ID: 29440986
[TBL] [Abstract][Full Text] [Related]
10. Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies.
Combs B; Kanaan NM
Am J Pathol; 2017 Jun; 187(6):1222-1229. PubMed ID: 28413156
[TBL] [Abstract][Full Text] [Related]
11. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.
Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M
Neurobiol Aging; 2016 Dec; 48():135-142. PubMed ID: 27676333
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
Hasegawa M
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.
Valera E; Spencer B; Masliah E
Neurotherapeutics; 2016 Jan; 13(1):179-89. PubMed ID: 26494242
[TBL] [Abstract][Full Text] [Related]
14. Impaired APP activity and altered Tau splicing in embryonic stem cell-derived astrocytes obtained from an APPsw transgenic minipig.
Hall VJ; Lindblad MM; Jakobsen JE; Gunnarsson A; Schmidt M; Rasmussen MA; Volke D; Zuchner T; Hyttel P
Dis Model Mech; 2015 Oct; 8(10):1265-78. PubMed ID: 26398935
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.
Valera E; Masliah E
Pharmacol Ther; 2013 Jun; 138(3):311-22. PubMed ID: 23384597
[TBL] [Abstract][Full Text] [Related]
16. CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.
Bendlin BB; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Willette AA; Okonkwo OC; Sodhi A; Ries ML; Birdsill AC; Alexander AL; Rowley HA; Puglielli L; Asthana S; Sager MA
PLoS One; 2012; 7(6):e37720. PubMed ID: 22701578
[TBL] [Abstract][Full Text] [Related]
17. RETRACTED: Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.
Khandelwal PJ; Dumanis SB; Herman AM; Rebeck GW; Moussa CE
Mol Cell Neurosci; 2012 Jan; 49(1):44-53. PubMed ID: 21945393
[TBL] [Abstract][Full Text] [Related]
18. The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies.
Stone JG; Siedlak SL; Tabaton M; Hirano A; Castellani RJ; Santocanale C; Perry G; Smith MA; Zhu X; Lee HG
J Neuropathol Exp Neurol; 2011 Jul; 70(7):578-87. PubMed ID: 21666500
[TBL] [Abstract][Full Text] [Related]
19. The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases.
Khandelwal PJ; Moussa CE
Front Psychiatry; 2010; 1():15. PubMed ID: 21423426
[TBL] [Abstract][Full Text] [Related]
20. Neuropathology of Alzheimer's disease.
Perl DP
Mt Sinai J Med; 2010; 77(1):32-42. PubMed ID: 20101720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
